NSE · PARKHOSPS
Park Medi World Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹34 Cr with net profit ₹1 Cr — a 3.22% net margin, versus 15.09% the period before.
Shareholding
As of 2026-09-30
- Promoter82.9%
- Public10.44%
- FII0.88%
- DII5.78%
54,391 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.21× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #16 of 86 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,21,469 Cr | 57.73 | 12.74 | 20.48% | 7.91% |
| Manipal Health Enterpri Limited | ₹88,018 Cr | 93.85 | 5.36 | 10.59% | 7.81% |
| Max Healthcare Institute Ltd. | ₹83,705 Cr | 55.92 | 7.79 | 13.42% | 16.73% |
| Aster DM Quality Care Ltd. | ₹59,570 Cr | 153.57 | 14.16 | 8.48% | 6.54% |
| Fortis Healthcare Ltd. | ₹58,117 Cr | 54.36 | 5.87 | 10.53% | 11.02% |
| Narayana Hrudayalaya Ltd. | ₹35,154 Cr | 40.78 | 7.75 | 17.76% | 9% |
| Global Health Limited | ₹34,156 Cr | 59.67 | 8.62 | 14.05% | 11.88% |
| Dr. Lal Path Labs Ltd. | ₹31,999 Cr | 56.89 | 12.76 | 20.13% | 18.75% |
| Krishna Institute of Medical Sciences Ltd. | ₹29,476 Cr | 141.21 | 7.87 | 10.74% | 4.85% |
| Dr. Agarwal's Health Care Limited | ₹16,144 Cr | 109.51 | 7.96 | 6.58% | 6.72% |
| Park Medi World Limited(this company) | ₹9,490 Cr | 34.17 | 4.72 | 12.77% | 15.81% |
AI analysis
AI-generated · google/gemini-2.5-flashPark Medi World Limited, operating in the Healthcare sector, has a market capitalization of Rs 11692 Cr. The company reported a profit margin of 15.11% and a revenue growth of 13.2%. The EPS stands at Rs 5.98 with a P/E ratio of 152.08.
Positives
- +The company's Return on Capital Employed (ROCE) is 17.3277%, indicating efficient use of capital.
- +The profit margin is 15.11%, suggesting good operational efficiency.
- +Promoter shareholding is substantial at 82.8949% as of June 30, 2026.
- +There are no promoter share pledges reported.
Negatives
- −The P/E ratio is high at 152.08.
- −The debt-to-equity ratio is 0.71, which indicates a moderate level of debt.
- −FII holding has decreased from 1.2763% in December 2025 to 0.8211% in June 2026.
Financial Performance
For the financial year ending March 2025, Park Medi World Limited reported revenue of Rs 1425.974 Cr and a net profit of Rs 205.163 Cr. The earnings per share (EPS) for this period was Rs 5.55. Revenue growth was 13.2% as per available data. The company's profit margin is 15.11%.
Profitability & Returns
The company's Return on Equity (ROE) is 12.77%, while its Return on Capital Employed (ROCE) is 17.3277%. The latest reported EPS is Rs 5.98. The P/E ratio is 152.08, and the book value per share is Rs 46.54.
Balance Sheet
Park Medi World Limited has a debt-to-equity ratio of 0.71. The company's book value per share is Rs 46.54. No information on current assets or liabilities is available in the provided data.
Ownership & Pledges
The total institutional holding stands at 9.7739%. There are no promoter share pledges reported.
Regulatory & Surveillance
There is no information provided regarding any regulatory actions or inclusion in surveillance frameworks such as the ASM or GSM lists for Park Medi World Limited.
Data as of — price: 2026-10-31 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.